Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Prostate specific antigen")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5362

  • Page / 215
Export

Selection :

  • and

Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapyPOLLACK, Alan; HANLON, Alexandra L; MOVSAS, Benjamin et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 19-23, issn 0360-3016, 5 p.Article

Prostate cancer: progression of prostate-specific antigen after external beam irradiationDAYANANDA, P. W. A; TAYLOR, J. M. G; WHITING, D. G et al.Mathematical biosciences. 2003, Vol 182, Num 2, pp 127-134, issn 0025-5564, 8 p.Article

Evaluation of the houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time biasPICKLES, Tom; KIM-SING, Charmaine; MORRIS, W. James et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 11-18, issn 0360-3016, 8 p.Article

An aptamer based resonance light scattering assay of prostate specific antigenZHANGUANG CHEN; LEI, Yulong; XI CHEN et al.Biosensors & bioelectronics. 2012, Vol 36, Num 1, pp 35-40, issn 0956-5663, 6 p.Article

A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigenLIN, Ying-Ying; JUN WANG; GUODONG LIU et al.Biosensors & bioelectronics. 2008, Vol 23, Num 11, pp 1659-1665, issn 0956-5663, 7 p.Article

3D label-free prostate specific antigen (PSA) immunosensor based on graphene-gold compositesHEE DONG JANG; SUN KYUNG KIM; HANKWON CHANG et al.Biosensors & bioelectronics. 2015, Vol 63, pp 546-551, issn 0956-5663, 6 p.Article

Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studiesGALLO, Maria F; SNEAD, Margaret C; BLACK, Carolyn M et al.Contraception (Stoneham). 2013, Vol 87, Num 6, pp 830-835, issn 0010-7824, 6 p.Article

Condom type may influence sexual behavior and ejaculation and complicate the assessment of condom functionalityHADDAD, Lisa; GALLO, Maria F; JAMIESON, Denise J et al.Contraception (Stoneham). 2012, Vol 86, Num 4, pp 391-396, issn 0010-7824, 6 p.Article

Selection of RNA aptamers specific to active prostate-specific antigenJEONG, Sujin; SEUNG RYUL HAN; YOUNG JU LEE et al.Biotechnology letters. 2010, Vol 32, Num 3, pp 379-385, issn 0141-5492, 7 p.Article

Baseline Prostate-Specific Antigen Testing at a Young AgeLOEB, Stacy; CARTER, H. Ballentine; CATALONA, William J et al.European urology. 2012, Vol 61, Num 1, pp 1-7, issn 0302-2838, 7 p.Article

Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activityKOLLARA, Alexandra; BROWN, Theodore J.Journal of steroid biochemistry and molecular biology. 2010, Vol 118, Num 1-2, pp 51-58, issn 0960-0760, 8 p.Article

Pt nanoparticle label-mediated deposition of Pt catalyst for ultrasensitive electrochemical immunosensorsJIE ZHANG; BOON PING TING; KHAN, Majad et al.Biosensors & bioelectronics. 2010, Vol 26, Num 2, pp 418-423, issn 0956-5663, 6 p.Article

Multiplexed BioCD for prostate specific antigen detectionXUEFENG WANG; MING ZHAO; NOLTE, David D et al.Proceedings of SPIE, the International Society for Optical Engineering. 2008, pp 68480S.1-68480S.8, issn 0277-786X, isbn 978-0-8194-7023-2, 1VolConference Paper

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up : Importance of patient selection and implant qualityKOLLMEIER, Marisa A; STOCK, Richard G; STONE, Nelson et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 645-653, issn 0360-3016, 9 p.Article

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995THAMES, Howard; KUBAN, Deborah; ZELEFSKY, Michael et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 929-943, issn 0360-3016, 15 p.Conference Paper

External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: Impact of pretreatment PSA value on radiotherapeutic outcomesAKIMOTO, Tetsuo; KITAMOTO, Yoshizumi; MITSUHASHI, Norio et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 2, pp 372-379, issn 0360-3016, 8 p.Article

Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomyKALAPURAKAL, John A; HUANG, Cheng-Fang; NERIAMPARAMPIL, Manoj M et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1047-1054, issn 0360-3016, 8 p.Article

EVALUATING THE PHOENIX DEFINITION OF BIOCHEMICAL FAILURE AFTER 125I PROSTATE BRACHYTHERAPY: CAN PSA KINETICS DISTINGUISH PSA FAILURES FROM PSA BOUNCES?THOMPSON, Anna; KEYES, Mira; PICKLES, Tom et al.International journal of radiation oncology, biology, physics. 2010, Vol 78, Num 2, pp 415-421, issn 0360-3016, 7 p.Article

Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancerSELEK, Ugur; LEE, Andrew; LEVY, Lawrence et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 963-967, issn 0360-3016, 5 p.Article

In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasiaPARK, H. S; CHEON, J; CHO, H. Y et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 13, pp 1129-1134, issn 0969-7128, 6 p.Article

Applying complexed prostate-specific antigen to clinical practicePARSONS, J. Kellogg; PARTIN, Alan W.Urology (Ridgewood, NJ). 2004, Vol 63, Num 5, pp 815-818, issn 0090-4295, 4 p.Article

Potential survival advantage with early androgen deprivation for biochemical failure after external beam radiotherapy: The importance of accurately defining biochemical disease statusKESTIN, Larry L; VICINI, Frank A; MARTINEZ, Alvaro A et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 2, pp 453-462, issn 0360-3016, 10 p.Article

Effect of hemodialysis on serum complexed prostate-specific antigen levelsTARHAN, Fatih; ORCUN, Asuman; KÜCÜKERCAN, Inci et al.Scandinavian journal of urology and nephrology. 2007, Vol 41, Num 5, pp 382-386, issn 0036-5599, 5 p.Article

Characterization and measurement of prostate-specific antigen using monoclonal antibodiesBELANGER, A; PEI MIN RONG; SHA LIU et al.Clinical and investigative medicine. 1993, Vol 16, Num 6, pp 409-414, issn 0147-958XArticle

Association between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsyJAE HEON KIM; SANG WOOK LEE; CHANGHO LEE et al.Journal of international medical research. 2014, Vol 42, Num 3, pp 821-827, issn 0300-0605, 7 p.Article

  • Page / 215